Endocrinology

Immune-related adverse events

Questions discussed in this category

How would you advise medical oncologists who recommend checkpoint inhibitors for a patient with baseline type 1 diabetes?

Some oncologists may have concerns that checkpoint inhibitors could diminish islet cell reserve and lead to worsening DM control.

3 Answers available

Do you initiate management of new onset diabetes in a patient on immunotherapy or refer immediately to endocrinology given the risk of rapid worsening?

1 Answer available

Papers discussed in this category

International immunopharmacology, 2023 Jun 28

Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus.

Related Topics in Endocrinology